These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
263 related articles for article (PubMed ID: 15897912)
1. Human Cripto-1 overexpression in the mouse mammary gland results in the development of hyperplasia and adenocarcinoma. Wechselberger C; Strizzi L; Kenney N; Hirota M; Sun Y; Ebert A; Orozco O; Bianco C; Khan NI; Wallace-Jones B; Normanno N; Adkins H; Sanicola M; Salomon DS Oncogene; 2005 Jun; 24(25):4094-105. PubMed ID: 15897912 [TBL] [Abstract][Full Text] [Related]
2. Overexpression of human Cripto-1 in transgenic mice delays mammary gland development and differentiation and induces mammary tumorigenesis. Sun Y; Strizzi L; Raafat A; Hirota M; Bianco C; Feigenbaum L; Kenney N; Wechselberger C; Callahan R; Salomon DS Am J Pathol; 2005 Aug; 167(2):585-97. PubMed ID: 16049342 [TBL] [Abstract][Full Text] [Related]
3. Cripto: a novel epidermal growth factor (EGF)-related peptide in mammary gland development and neoplasia. Salomon DS; Bianco C; De Santis M Bioessays; 1999 Jan; 21(1):61-70. PubMed ID: 10070255 [TBL] [Abstract][Full Text] [Related]
4. NDF/heregulin induces persistence of terminal end buds and adenocarcinomas in the mammary glands of transgenic mice. Krane IM; Leder P Oncogene; 1996 Apr; 12(8):1781-8. PubMed ID: 8622899 [TBL] [Abstract][Full Text] [Related]
5. Epithelial mesenchymal transition is a characteristic of hyperplasias and tumors in mammary gland from MMTV-Cripto-1 transgenic mice. Strizzi L; Bianco C; Normanno N; Seno M; Wechselberger C; Wallace-Jones B; Khan NI; Hirota M; Sun Y; Sanicola M; Salomon DS J Cell Physiol; 2004 Nov; 201(2):266-76. PubMed ID: 15334661 [TBL] [Abstract][Full Text] [Related]
6. Development of leiomyosarcoma of the uterus in MMTV-CR-1 transgenic mice. Strizzi L; Bianco C; Hirota M; Watanabe K; Mancino M; Hamada S; Raafat A; Lawson S; Ebert AD; D'Antonio A; Losito S; Normanno N; Salomon DS J Pathol; 2007 Jan; 211(1):36-44. PubMed ID: 17072826 [TBL] [Abstract][Full Text] [Related]
7. A mouse mammary tumor virus-Wnt-1 transgene induces mammary gland hyperplasia and tumorigenesis in mice lacking estrogen receptor-alpha. Bocchinfuso WP; Hively WP; Couse JF; Varmus HE; Korach KS Cancer Res; 1999 Apr; 59(8):1869-76. PubMed ID: 10213494 [TBL] [Abstract][Full Text] [Related]
8. Expression of epidermal growth factor-related proteins in the aged adult mouse mammary gland and their relationship to tumorigenesis. Herrington EE; Ram TG; Salomon DS; Johnson GR; Gullick WJ; Kenney N; Hosick HL J Cell Physiol; 1997 Jan; 170(1):47-56. PubMed ID: 9012784 [TBL] [Abstract][Full Text] [Related]
9. Myc/p53 interactions in transgenic mouse mammary development, tumorigenesis and chromosomal instability. McCormack SJ; Weaver Z; Deming S; Natarajan G; Torri J; Johnson MD; Liyanage M; Ried T; Dickson RB Oncogene; 1998 May; 16(21):2755-66. PubMed ID: 9652742 [TBL] [Abstract][Full Text] [Related]
10. Transforming growth factor-alpha promotes mammary tumorigenesis through selective survival and growth of secretory epithelial cells. Smith GH; Sharp R; Kordon EC; Jhappan C; Merlino G Am J Pathol; 1995 Oct; 147(4):1081-96. PubMed ID: 7573353 [TBL] [Abstract][Full Text] [Related]
11. Detection of amphiregulin and Cripto-1 in mammary tumors from transgenic mice. Kenney NJ; Smith GH; Maroulakou IG; Green JH; Muller WJ; Callahan R; Salomon DS; Dickson RB Mol Carcinog; 1996 Jan; 15(1):44-56. PubMed ID: 8561865 [TBL] [Abstract][Full Text] [Related]
12. Cripto-1: an oncofetal gene with many faces. Bianco C; Strizzi L; Normanno N; Khan N; Salomon DS Curr Top Dev Biol; 2005; 67():85-133. PubMed ID: 15949532 [TBL] [Abstract][Full Text] [Related]
13. Wnt-10b directs hypermorphic development and transformation in mammary glands of male and female mice. Lane TF; Leder P Oncogene; 1997 Oct; 15(18):2133-44. PubMed ID: 9393971 [TBL] [Abstract][Full Text] [Related]
14. Netrin-1 regulates invasion and migration of mouse mammary epithelial cells overexpressing Cripto-1 in vitro and in vivo. Strizzi L; Bianco C; Raafat A; Abdallah W; Chang C; Raafat D; Hirota M; Hamada S; Sun Y; Normanno N; Callahan R; Hinck L; Salomon D J Cell Sci; 2005 Oct; 118(Pt 20):4633-43. PubMed ID: 16176936 [TBL] [Abstract][Full Text] [Related]
15. Keratinocyte growth factor induces mammary and prostatic hyperplasia and mammary adenocarcinoma in transgenic mice. Kitsberg DI; Leder P Oncogene; 1996 Dec; 13(12):2507-15. PubMed ID: 9000125 [TBL] [Abstract][Full Text] [Related]
17. Local over-expression of prolactin in differentiating mouse mammary gland induces functional defects and benign lesions, but no carcinoma. Manhès C; Kayser C; Bertheau P; Kelder B; Kopchick JJ; Kelly PA; Touraine P; Goffin V J Endocrinol; 2006 Aug; 190(2):271-85. PubMed ID: 16899561 [TBL] [Abstract][Full Text] [Related]
18. Transgenic mice with mammary gland targeted expression of human cortactin do not develop (pre-malignant) breast tumors: studies in MMTV-cortactin and MMTV-cortactin/-cyclin D1 bitransgenic mice. van Rossum AG; van Bragt MP; Schuuring-Scholtes E; van der Ploeg JC; van Krieken JH; Kluin PM; Schuuring E BMC Cancer; 2006 Mar; 6():58. PubMed ID: 16536875 [TBL] [Abstract][Full Text] [Related]
19. Cripto: roles in mammary cell growth, survival, differentiation and transformation. Niemeyer CC; Persico MG; Adamson ED Cell Death Differ; 1998 May; 5(5):440-9. PubMed ID: 10200494 [TBL] [Abstract][Full Text] [Related]
20. Preneoplastic mammary tumor markers: Cripto and Amphiregulin are overexpressed in hyperplastic stages of tumor progression in transgenic mice. Niemeyer CC; Spencer-Dene B; Wu JX; Adamson ED Int J Cancer; 1999 May; 81(4):588-91. PubMed ID: 10225449 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]